[Antineoplastic drug-induced nausea and vomiting in pediatric onco-hematology: 2022: Guidelines from the supportive care committee of the French Society of Childhood Cancer (SFCE)].

MLA

Thouvenin-Doulet, Sandrine, et al. “[Antineoplastic Drug-Induced Nausea and Vomiting in Pediatric Onco-Hematology: 2022: Guidelines from the Supportive Care Committee of the French Society of Childhood Cancer (SFCE)].” Bulletin Du Cancer, vol. 109, no. 11, Nov. 2022, pp. 1144–53. EBSCOhost, https://doi.org/10.1016/j.bulcan.2022.08.003.

APA

Thouvenin-Doulet, S., Mouffak, S., Bertrand, A., Cardine, A. M., Letort-Bertrand, M., Levy, D., Wiart-Monger, V., Lervat, C., & Poirée, M. (2022). [Antineoplastic drug-induced nausea and vomiting in pediatric onco-hematology: 2022: Guidelines from the supportive care committee of the French Society of Childhood Cancer (SFCE)]. Bulletin Du Cancer, 109(11), 1144–1153. https://doi.org/10.1016/j.bulcan.2022.08.003

Chicago

Thouvenin-Doulet, Sandrine, Samia Mouffak, Amandine Bertrand, Aude Marie Cardine, Maïna Letort-Bertrand, Dominique Levy, Virginie Wiart-Monger, Cyril Lervat, and Marilyne Poirée. 2022. “[Antineoplastic Drug-Induced Nausea and Vomiting in Pediatric Onco-Hematology: 2022: Guidelines from the Supportive Care Committee of the French Society of Childhood Cancer (SFCE)].” Bulletin Du Cancer 109 (11): 1144–53. doi:10.1016/j.bulcan.2022.08.003.